Table 8. Comparison of the diagnostic efficacy of MRI for HCC tumors of various liver parenchymal fibrosis stages (tumor size: >2cm).
Fibrosis 4 | Fibrosis 0–3 | P value | |
(cirrhosis) | (non-cirrhosis) | ||
Sensitivity | 43/48 (89.6%) | 34/43 (79.1%) | 0.165 |
Specificity | 2/2 (100%) | 43/53 (81.1%) | 1.000 |
PPV | 43/43 (100%) | 34/44 (77.3%) | 0.001 |
NPV | 2/7 (28.6%) | 43/52 (82.7%) | 0.006 |
Accuracy | 45/50 (90%) | 77/96 (80.2%) | 0.130 |
Fibrosis 3–4 | Fibrosis 0–2 | ||
Sensitivity | 52/58 (89.7%) | 23/30 (76.7%) | 0.122 |
Specificity | 1/2 (50%) | 5/7 (71.4%) | 1.000 |
PPV | 52/53 (98.1%) | 23/25 (92%) | 0.239 |
NPV | 1/7 (14.3%) | 5/12 (41.7%) | 0.333 |
Accuracy | 53/60 (88.3%) | 28/37 (75.7%) | 0.103 |
Fibrosis 2–4 | Fibrosis 0–1 | ||
Sensitivity | 54/60 (90%) | 21/28 (75%) | 0.104 |
Specificity | 1/2 (50%) | 5/7 (71.4%) | 1.000 |
PPV | 54/55 (98.2%) | 21/23 (91.3%) | 0.206 |
NPV | 1/7 (14.3%) | 5/12 (41.7%) | 0.333 |
Accuracy | 55/62 (88.7%) | 26/35 (74.3%) | 0.066 |
Fibrosis 1–4 | Fibrosis 0 | ||
Sensitivity | 65/74 (87.8%) | 10/14 (71.4%) | 0.210 |
Specificity | 2/4 (50%) | 4/5 (80%) | 0.524 |
PPV | 65/67 (97%) | 10/11 (90.9%) | 0.370 |
NPV | 2/11 (18.2%) | 4/8 (50%) | 0.319 |
Accuracy | 67/78 (85.9%) | 14/19 (73.7%) | 0.298 |
PPV, positive predictive value; NPV, negative predictive value